MedPath

Thin Bronchoscope and Virtual Bronchoscopic Navigation System for Tuberculosis

Not Applicable
Completed
Conditions
Tuberculosis
Registration Number
NCT03802812
Lead Sponsor
Pusan National University Hospital
Brief Summary

This study investigates the utility of thin bronchoscope and virtual bronchoscopic navigation system (targeted bronchial washing) for detection of M. tuberculosis and resistant-conferring mutations in patients with pulmonary tuberculosis. Time to appropriate treatment and stain/culture conversion are also evaluated.

Detailed Description

Comparisons of detection rate of M. tuberculosis and resistant-conferring mutations between patients who perform CT-guided conventional bronchoscope and patients who perform VBN-guided thin bronchoscope.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • age of 18 or more
  • persons who are suspected with pulmonary tuberculosis on radiologic examination
  • persons who cannot spit sputum or persons with negative results on sputum AFB smear and TB-PCR or Xpert MTB/RIF assay
Exclusion Criteria
  • persons who do not agree with bronchoscopy (persons who want empirical treatment for TB)

  • persons with contraindications for bronchoscopy

    • bleeding tendency
    • uncontrolled respiratory disease (hypoxemia)
    • uncontrolled cardiovascular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
detection of M. tuberculosis and resistant-conferring mutations2months after procedure

evaulation by sensitivity, specificity, PPV and NPV

Secondary Outcome Measures
NameTimeMethod
time to appropriate treatment and stain/culture conversion6months after procedure

date of treatment initiation and stain/culture negative conversion

Trial Locations

Locations (1)

Pusan National University Hospital

🇰🇷

Busan, Korea, Republic of

Pusan National University Hospital
🇰🇷Busan, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.